Abstract
ObjectivesJuvenile myoclonic epilepsy (JME) is a common form of generalized epilepsy with an important genetic component. This cohort study aimed to examine the frequency of EFHC1 gene variants in Turkish JME patients and a healthy control group and evaluate the association between these mutations and disease risk. MethodsWe screened 72 JME patients with a mean age of 31.8 ± 9.9 (20–65) years and 35 controls with a mean age of 29.1 ± 7.6 (17–50) years from southern Turkey using direct sequencing analyses. ResultsEFCH1 single nucleotide variants were detected in 24 of 72 JME patients and 3 of 35 controls. The most common mutations were R182H in JME patients (p = 0.010) and 3′UTR in the control group (p < 0.001). The R182H mutation is a common variant in JME (95 % CI: 1.232–76.580, p = 0.031) and the 3′UTR mutation may be associated with lower risk of JME in the Turkish population (95 % CI: 13.89–166.67, p < 0.001). SignificanceOur results indicate that EFHC1 gene variants carry a risk for JME and the 3′UTR variant may have a protective role against JME in the Turkish population. Screening for other genes is needed to further clarify the genetic inheritance of JME in Turkish patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have